Patient Care

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies,...

Wellstar Health System Rolls Out the Swift™ AI Scheduling Copilot for Nursing Teams, the First Workforce Solution by vflok Inc.

ATLANTA, Sept. 18, 2025 /PRNewswire/ -- Workforce AI startup vflok™ Inc. is improving schedule flexibility and eliminating unnecessary workflows for...

Industry Leaders Adonis and CaduceusHealth Join Forces to Lead the Next Chapter of AI Innovation in Revenue Cycle Management

Collaboration highlights CaduceusHealth's commitment to enhance client financial health for AthenaHealth customers by adopting cutting-edge technologies. NEW YORK, Sept. 17,...

error: Content is protected !!